StageAcquired | Acquired
About Green Gene Research
Green Gene controls a portfolio of laboratory-tested craft Cannabis strains. These craft strains will allow for the continued differentiation of the International Cannabis brand, in an increasingly generic and homogenized market.
Missing: Green Gene Research's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Green Gene Research's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Green Gene Research
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Green Gene Research is included in 1 Expert Collection, including Cannabis.
These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.
Latest Green Gene Research News
Feb 7, 2019
. (CSE: WRLD)(FWB: 8K51)(OTC: KNHBF) ("ICC" or “International Cannabis” or the “Company”) announces that it has received inquiries from the British Columbia Securities Commission (the “BCSC”) with respect to its agreement involving Green Gene Research Inc. (see news release dated Nov. 20, 2018). The Company is cooperating fully with the BCSC, and does not expect that the inquiries will interfere with the Company's day-to-day activities. The Company is reviewing the agreement, and is working with legal counsel to determine its next steps. ON BEHALF OF THE ICC INTERNATIONAL CANNABIS CORP BOARD OF DIRECTORS “Eugene Beukman” THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. Notice Regarding Forward Looking Information: This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: political changes in Canada and internationally, future legislative and regulatory developments involving cannabis in Canada and internationally, the Company’s ability to secure distribution channels in international jurisdictions, competition and other risks affecting the Company in particular and the cannabis industry generally. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward- looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Related Articles
Green Gene Research Frequently Asked Questions (FAQ)
What is Green Gene Research's latest funding round?
Green Gene Research's latest funding round is Acquired.
Who are the investors of Green Gene Research?
Investors of Green Gene Research include ICC International Cannabis.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.